EZH2 and breast carcinoma: Building on our previous study showing that EZH2 binds to p38α MAPK in ER- breast cancer cells and leads to p38 MAPK signaling activation15, here we document direct and strong nanomolar binding affinity of EZH2 to p38α using Biolayer Interferometry.